Advances in resistance mechanisms and counterstrategies for antibody?drug conjugates in HER2?low and HER2?ultralow breast cancer (Review). Yu X, Ren M, Yao L. Oncol Rep 2026;56:208.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu X, Ren M, Yao L. Advances in resistance mechanisms and counterstrategies for antibody?drug conjugates in HER2?low and HER2?ultralow breast cancer (Review). Oncol Rep 2026;56:208.
PMID: 42924615